Cite
In Adult Acute Lymphoblastic Leukemia End of Induction MRD Correlates Strongly with Subsequent Key Timepoints and Predicts Long Term Outcome
MLA
Tamara Intermesoli, et al. “In Adult Acute Lymphoblastic Leukemia End of Induction MRD Correlates Strongly with Subsequent Key Timepoints and Predicts Long Term Outcome.” Clinical Lymphoma Myeloma and Leukemia, vol. 17, Sept. 2017, pp. S262–63. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........c20f5f96069bcae0cd8c83782e2a50a6&authtype=sso&custid=ns315887.
APA
Tamara Intermesoli, Orietta Spinelli, Chiara Pavoni, Manuela Tosi, Elena Maino, Ernesta Audisio, Claudio Romani, Arianna Masciulli, Agostino Cortelezzi, Alessandro Rambaldi, Monica Fumagalli, Chiara Cattaneo, Anna Maria Scattolin, Vincenzo Cassibba, Fabio Ciceri, Renato Bassan, Daniele Mattei, & Elena Oldani. (2017). In Adult Acute Lymphoblastic Leukemia End of Induction MRD Correlates Strongly with Subsequent Key Timepoints and Predicts Long Term Outcome. Clinical Lymphoma Myeloma and Leukemia, 17, S262–S263.
Chicago
Tamara Intermesoli, Orietta Spinelli, Chiara Pavoni, Manuela Tosi, Elena Maino, Ernesta Audisio, Claudio Romani, et al. 2017. “In Adult Acute Lymphoblastic Leukemia End of Induction MRD Correlates Strongly with Subsequent Key Timepoints and Predicts Long Term Outcome.” Clinical Lymphoma Myeloma and Leukemia 17 (September): S262–63. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........c20f5f96069bcae0cd8c83782e2a50a6&authtype=sso&custid=ns315887.